| Name: | Celecoxib N-Oxide |
| Catalogue No. | VE008322 |
| CAS No. | N/A |
| Molecular Formula | C17H14F3N3O3S |
| Molecular Weight | 397.37 g/mol |
| Status | Under Development |
| IUPAC Name | 1-(4-sulfamoylphenyl)-5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazole 1-oxide |
| Description | Celecoxib N-Oxide(CAS No: N/A) or 1-(4-sulfamoylphenyl)-5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazole 1-oxide,a selective cyclooxygenase-2 (COX-2) inhibitor that used to treat osteoarthritis,a platelet aggregation inhibitor acts By inhibiting prostaglandin synthesis |
| References | Xu, Chao, et al. “Efficacy and Safety of Celecoxib Therapy in Osteoarthritis.” Medicine, vol. 95, no. 20, May 2016, p. e3585, https://doi.org/10.1097/md.0000000000003585. |
